BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9717201)

  • 1. Myeloma overview.
    Soutar RL
    Scott Med J; 1998 Apr; 43(2):38-41. PubMed ID: 9717201
    [No Abstract]   [Full Text] [Related]  

  • 2. [High-dose chemotherapy and bone marrow graft in multiple myeloma: hopes and limits].
    Ravaud P; Fermand JP
    Rev Rhum Ed Fr; 1993 Apr; 60(4):266-8. PubMed ID: 8167622
    [No Abstract]   [Full Text] [Related]  

  • 3. [Advances in the treatment of refractory multiple myeloma].
    Lu SP
    Zhonghua Nei Ke Za Zhi; 1990 Mar; 29(3):178-80. PubMed ID: 2209248
    [No Abstract]   [Full Text] [Related]  

  • 4. [Multiple myeloma in 1990].
    Le Loët X; Monconduit M; Euller-Ziegler L
    Ann Med Interne (Paris); 1990; 141(2):108-10. PubMed ID: 2191611
    [No Abstract]   [Full Text] [Related]  

  • 5. Melphalan/prednisone versus melphalan/prednisone plus human alpha interferon therapy in patients with multiple myeloma, stages II and III. Myeloma Group of Central Sweden.
    Björkholm M
    Eur J Cancer; 1991; 27 Suppl 4():S51-2. PubMed ID: 1799480
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current and future approaches to therapy for multiple myeloma].
    Nara N
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):9-15. PubMed ID: 7826084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and therapy of multiple myeloma: current aspects].
    Betticher DC; Cerny T; Fey MF
    Schweiz Med Wochenschr; 1995 Mar; 125(11):541-51. PubMed ID: 7899848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of multiple myeloma.
    San Miguel JF; Bladé Creixenti J; García-Sanz R
    Haematologica; 1999 Jan; 84(1):36-58. PubMed ID: 10091392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple myeloma.
    Mehta GR; Suhail F; Haddad RY; Zalzaleh G; Lerma EV
    Dis Mon; 2014 Oct; 60(10):483-8. PubMed ID: 25288376
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomized trial of interferon maintenance in multiple myeloma: a study of the National Cancer Institute of Canada Clinical Trials Group.
    Browman GP; Bergsagel D; Sicheri D; O'Reilly S; Wilson KS; Rubin S; Belch A; Shustik C; Barr R; Walker I
    J Clin Oncol; 1995 Sep; 13(9):2354-60. PubMed ID: 7666094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multiple myeloma: the therapeutic options].
    Sánchez Fayos J; Prieto E; Roman A; Olavarria E
    An Med Interna; 1992 Feb; 9 Spec No():112-8. PubMed ID: 1550902
    [No Abstract]   [Full Text] [Related]  

  • 12. Evolution of multiple myeloma treatment from melphalan monotherapy to bone marrow transplantation.
    Hájek R; Adam Z; Vásová I; Král Z
    Acta Med Austriaca; 1996; 23(3):85-91. PubMed ID: 8798281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the treatment of multiple myeloma.
    Lokhorst HM; Dekker AW
    Cancer Treat Rev; 1993 Apr; 19(2):113-28. PubMed ID: 7683253
    [No Abstract]   [Full Text] [Related]  

  • 14. Advances in the treatment of multiple myeloma.
    Barlogie B; Jagannath S; Tricot G; Desikan KR; Fassas A; Siegel D
    Adv Intern Med; 1998; 43():279-320. PubMed ID: 9506186
    [No Abstract]   [Full Text] [Related]  

  • 15. Who benefits from high-dose therapy for multiple myeloma?
    Anderson KC
    J Clin Oncol; 1995 Jun; 13(6):1291-6. PubMed ID: 7751873
    [No Abstract]   [Full Text] [Related]  

  • 16. [Multiple myeloma. Biological, prognostic, and therapeutic aspects].
    Corrado C; Pavlovsky S
    Sangre (Barc); 1990 Aug; 35(4):289-97. PubMed ID: 1703328
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recent therapy for refractory myeloma].
    Togawa A
    Rinsho Ketsueki; 1993 Apr; 34(4):450-4. PubMed ID: 8510332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.
    Kyle RA
    Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose melphalan with autotransplantation for refractory multiple myeloma: results of a Southwest Oncology Group phase II trial.
    Vesole DH; Crowley JJ; Catchatourian R; Stiff PJ; Johnson DB; Cromer J; Salmon SE; Barlogie B
    J Clin Oncol; 1999 Jul; 17(7):2173-9. PubMed ID: 10561273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of multiple myeloma].
    La Verde G; Pulsoni A; Petrucci MT; Mandelli F
    Recenti Prog Med; 1997 Apr; 88(4):186-93. PubMed ID: 9206817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.